Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced 26.8% after settling disputes with United Therapeutics, preserving its drug's availability for pulmonary arterial hypertension. These moves highlight strong investor interest and strategic settlements impacting stock performance.
Liquidia Corporation shares are up 25.59% on Pluang, trading at USD 33.67 with a market cap of $2.40 billion. Buy orders make up 62% of activity, indicating strong interest. These figures are current as of Oct 15, 2026 04:41 WIB.
Liquidia Corporation's shares rose 25% to $33.47 following a settlement of six pending lawsuits with United Therapeutics, ending years of patent and antitrust disputes. The settlement removes legal uncertainty around Liquidia's inhaled treprostinil t...
Liquidia and United Therapeutics resolved their patent dispute with Liquidia agreeing to pay $380.7 million, leading to a 42.6% rise in Liquidia's stock. The settlement ends multiple lawsuits and forces Liquidia to remove a use indication from its dr...
